Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Update on St. John's Wort.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2010 Nov;48(11):20-4. doi: 10.3928/02793695-20100930-99.

PMID:
21053786
2.

The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).

Markowitz JS, DeVane CL.

Psychopharmacol Bull. 2001 Winter;35(1):53-64. Review.

PMID:
12397870
3.

St John's wort and depression: slight efficacy at best, many drug interactions.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):187-92.

PMID:
15499702
4.

St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.

Barnes J, Anderson LA, Phillipson JD.

J Pharm Pharmacol. 2001 May;53(5):583-600. Review.

PMID:
11370698
5.

The safety of St. John's wort (Hypericum perforatum) during breastfeeding.

Lee A, Minhas R, Matsuda N, Lam M, Ito S.

J Clin Psychiatry. 2003 Aug;64(8):966-8.

PMID:
12927015
6.

St. John's wort - an overview.

Linde K.

Forsch Komplementmed. 2009 Jun;16(3):146-55. doi: 10.1159/000209290. Review.

7.

Clinical drugs that interact with St. John's wort and implication in drug development.

Di YM, Li CG, Xue CC, Zhou SF.

Curr Pharm Des. 2008;14(17):1723-42. Review.

PMID:
18673195
8.

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.

Izzo AA.

Int J Clin Pharmacol Ther. 2004 Mar;42(3):139-48. Review.

PMID:
15049433
9.

St John's wort (Hypericum perforatum) in major depression.

Shelton RC.

J Clin Psychiatry. 2009;70 Suppl 5:23-7. doi: 10.4088/JCP.8157su1c.05. Review.

10.

St. John's wort: a new alternative for depression?

Josey ES, Tackett RL.

Int J Clin Pharmacol Ther. 1999 Mar;37(3):111-9. Review.

PMID:
10190758
11.

A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.

Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.

J Clin Psychopharmacol. 2005 Oct;25(5):441-7.

PMID:
16160619
12.

[Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort].

Röder C, Schaefer M, Leucht S.

Fortschr Neurol Psychiatr. 2004 Jun;72(6):330-43. German.

PMID:
15211398
13.

An update on clinical drug interactions with the herbal antidepressant St. John's wort.

Zhou SF, Lai X.

Curr Drug Metab. 2008 Jun;9(5):394-409. Review.

PMID:
18537576
14.

A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review.

Whiskey E, Werneke U, Taylor D.

Int Clin Psychopharmacol. 2001 Sep;16(5):239-52. Review.

PMID:
11552767
15.

How effective is St John's wort? The evidence revisited.

Werneke U, Horn O, Taylor DM.

J Clin Psychiatry. 2004 May;65(5):611-7.

PMID:
15163246
16.

[St. John's wort: a pharmaceutical with potentially dangerous interactions].

Rätz AE, von Moos M, Drewe J.

Praxis (Bern 1994). 2001 May 10;90(19):843-9. German.

PMID:
11407242
17.

Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.

Solomon D, Adams J, Graves N.

J Affect Disord. 2013 Jun;148(2-3):228-34. doi: 10.1016/j.jad.2012.11.064.

PMID:
23291009
18.

St John's wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist.

Hammerness P, Basch E, Ulbricht C, Barrette EP, Foppa I, Basch S, Bent S, Boon H, Ernst E; Natural Standard Research Collaboration..

Psychosomatics. 2003 Jul-Aug;44(4):271-82. Review.

PMID:
12832592
19.

St. John's wort and depression: efficacy, safety and tolerability-an update.

Bilia AR, Gallori S, Vincieri FF.

Life Sci. 2002 May 17;70(26):3077-96. Review.

PMID:
12008092
20.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
Items per page

Supplemental Content

Support Center